Biopsy Doctors Abroad — Page 20

The doctor is a highly experienced dermatologist with over 15 years of clinical practice focusing on skin disorders, cosmetic dermatology, and laser treatments. They have published multiple peer-reviewed articles in leading dermatology journals and have been a speaker at international conferences. The doctor is board-certified in dermatology and has completed advanced training in dermatosurgery. They are committed to patient-centered care and stay updated with the latest advancements in dermatological treatments.

Professor Kim Jong-yeon is a gastroenterologist at Myongji Hospital. He treats diseases of the esophagus, stomach, colon, and liver, including cirrhosis and hepatitis. He performs therapeutic endoscopy, such as endoscopic polypectomy. He also serves as Deputy Director of the International Healthcare Center.

He is a member of the Liver Failure Center. He works with teams in hepatology, liver cancer, and transplantation to provide coordinated care for advanced liver disease and for transplant candidates.

MD, Jeonbuk National University College of Medicine. Clinical Professor of Gastroenterology at Myongji Hospital. Member of the Korean Association of Internal Medicine, the Korean Society of Gastroenterology, and the Korean Society of Gastrointestinal Endoscopy. Former resident and fellow at Inje University Ilsan Paik Hospital.

The doctor holds an MD in Radiation Oncology and serves as a consultant. Specializing in advanced cancer treatment techniques, the doctor offers services including Tomotherapy-H, Linear Accelerator, and Brachytherapy. These modalities are utilized to deliver precise radiation therapy, minimizing damage to surrounding healthy tissues and enhancing treatment efficacy.

Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.

• Expert in functional rehabilitation for patients recovering from oral cancer.
• Active researcher with multiple publications in various medical journals.
• Works at an NABH-accredited center that treats over 75,000 patients yearly.
• Treats complex conditions including tongue, thyroid, and tonsil cancers.

The doctor is a highly skilled urologist and oncosurgeon, specializing in the treatment of complex urological conditions and cancers. With extensive experience in both surgical and non-surgical interventions, the doctor is dedicated to advancing patient care through innovative techniques and personalized treatment plans. The doctor is recognized for contributing to the field through research and participation in professional medical societies.

The doctor is a urologist and oncosurgeon with a specialization in laparoscopic and robotic surgeries. With extensive experience in minimally invasive techniques, the doctor focuses on improving patient outcomes through advanced surgical methods.

The doctor is a highly experienced oncologist specializing in the treatment of various cancers, with a particular focus on breast and lung cancer. With over 20 years of clinical experience, the doctor has been involved in numerous groundbreaking research projects and clinical trials aimed at improving cancer treatment outcomes. The doctor is board-certified in oncology and has published extensively in leading medical journals. Additionally, the doctor is an active member of several prestigious oncology societies and frequently presents at international conferences.

The doctor is a highly experienced oncologist with over 20 years in the field, specializing in the treatment of breast and lung cancers. They have contributed to numerous clinical trials and have published extensively in peer-reviewed journals. Board-certified in medical oncology, the doctor has been recognized for their innovative approach to personalized cancer therapy.

They have served in leadership roles at top cancer centers, where they have implemented cutting-edge treatment protocols and led multidisciplinary teams. Their work has significantly improved patient outcomes and advanced the understanding of cancer biology.

The doctor is a highly experienced oncologist with a focus on advanced cancer treatments and personalized patient care. With over 20 years in the field, the doctor has contributed to numerous groundbreaking studies in oncology and has a particular interest in immunotherapy and targeted therapies. The doctor is board-certified in oncology and has been recognized for excellence in clinical practice and research. The doctor has published extensively in peer-reviewed journals and is frequently invited to speak at international conferences.

The doctor is a highly experienced oncologist with over 20 years in the field of cancer treatment. Specializing in breast and colorectal cancers, the doctor has contributed to numerous clinical trials and published extensively in peer-reviewed journals. Board-certified in medical oncology, the doctor is committed to advancing cancer care through innovative therapies and patient-centered approaches. The doctor has also been recognized with several awards for excellence in clinical research and patient care.

The doctor is a highly experienced oncologist with over 20 years in the field, specializing in breast and gastrointestinal cancers. They have contributed to numerous groundbreaking research studies and have published extensively in top medical journals. The doctor is board-certified and has been actively involved in clinical trials aimed at improving cancer treatment protocols.

They have received multiple awards for excellence in patient care and have been a keynote speaker at international oncology conferences. The doctor is committed to advancing cancer treatment through innovative therapies and patient-centered care.

The doctor is a highly skilled oncologist with extensive experience in the diagnosis and treatment of various cancers. Specializing in both medical and radiation oncology, the doctor has contributed significantly to clinical trials and research, advancing treatment protocols. With board certification in oncology, the doctor has received numerous awards for excellence in patient care and has published multiple peer-reviewed articles in leading medical journals. The doctor is dedicated to providing personalized treatment plans and is actively involved in educating future oncologists through teaching and mentorship roles.

Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.

He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.

Professor Park Jung-won is a leading Korean specialist in hepatocellular carcinoma with over 30 years of experience. He is the Director of the Liver and Liver Cancer Center and the Integrated Cancer Care Center at Myongji Hospital. He led Korea’s first HCC guidelines in 2003. He has also overseen their updates for about 20 years. His team validated proton beam radiotherapy for liver cancer, as published in the Journal of Hepatology. He has authored more than 200 SCI-indexed papers. He also helped lead global trials, including the 2025 CheckMate 9DW study, which showed improved outcomes with nivolumab plus ipilimumab for unresectable HCC.

MD/PhD, Seoul National University; Member, National Academy of Medicine of Korea; former President, Korean Liver Cancer Association; Chair, Korean HCC Guidelines Committee; Prime Minister’s and Health Minister’s commendations; Pfizer Medical Research Award and Roche Oncology Academic Award.